TARGETED IMMUNE THERAPY
USPTO Trademark Record · Serial No. 78707831
Trademark details
It was initially claimed by Idera on 20050907.
That brand applies to the following goods and services:Immunological products, biological, chemical and therapeutic preparations, chemical products, namely, synthetic oligonucleotides for use in the manufacture of pharmaceuticals for modulating the immune system, scientific research and development to enhance or induce the immune system response, medical diagnostic and therapeutic preparations, namely, biologically active modulators, including, immune modulators and antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for us, medical and scientific services namely provision of care in the field of immunology; medical and scientific research in the area of oligonucleotides or chemical products; research and development of pharmaceuticals and research products for others; biological and/or chemical research namely in the field of immunology, medical services, namely, providing medical care in the field of immunology.
Currently that trademark is represented by trademark attorney(s): Joseph C. Zucchero.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the TARGETED IMMUNE THERAPY trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
